Milan connects independent pharmacies and 340B clinic networks in New York with licensed secondary wholesalers. When a primary puts a drug on allocation, the patient is the one who waits.
Live FDA licensing and shortage data, pulled September 22, 2026. This is the market I watch.
- →782 distributors currently hold a New York wholesale license
- →138 of those listings show an expiry date already past
- →13 more New York licenses expire on September 30
- →Methylphenidate ER short at six manufacturers, updated this week
Sourced from the FDA wholesale distributor register and drug shortage database.
What I put in motion, step by step.
- Pharmacy on allocation → licensed secondary wholesaler When your primary caps an item or back-orders it, I find the licensed, accredited wholesaler that has it and ships into New York, and I check the registration before I send you anywhere.
- Wholesaler → the pharmacies and 340B networks that need a second source If you’re a licensed secondary or regional distributor, I bring you independent pharmacies and clinic networks asking for exactly what you carry, the week they start asking.
Verified before introduction. I check a wholesaler’s New York registration and accreditation myself before anyone gets an introduction, and I say no when it doesn’t hold up. Last week that ruled out two distributors whose New York licenses had lapsed. I work alongside myoProcess, a vetted B2B partner trusted across $1B+ in transactions.
What I see in this market that outsiders miss.